IMITREX STATDOSE

LOE Approaching

sumatriptan

NDASUBCUTANEOUSINJECTABLEPriority Review
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

5-HT 1B / 1D receptors. Sumatriptan presumably exerts its therapeutic effects in the treatment of migraine and cluster headaches through agonist effects at the 5-HT 1B / 1D receptors on intracranial blood vessels and sensory nerves of the trigeminal system, which result in cranial vessel…

Clinical Trials (5)

NCT04355845Phase 1Completed

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

Started Jun 2020
10 enrolled
Healthy Volunteers
NCT03310411Phase 1Completed

A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants

Started Oct 2017
40 enrolled
Healthy
NCT03076970Phase 1Completed

Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants

Started Mar 2017
42 enrolled
Migraine
NCT02741310Phase 1Completed

Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan

Started Feb 2016
34 enrolled
Healthy Subjects
NCT01248468Phase 4Completed

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Started Nov 2010
752 enrolled
Pain, Migraine